Neurological Disorders Clinical Trial
Official title:
Comparison of the Effectiveness of Complementary and Alternative Medicine (CAM) Therapies in Pediatric Patients Undergoing Medical Resonance Imagining (MRI) Studies
Verified date | May 2013 |
Source | Wayne State University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The investigators conducted a prospective open unblinded clinical four-arm evaluation of Complementary and Alternate Medicine (CAM) interventions on children 1-12 years of age who were undergoing imaging by Medical Resonance Imaging(MRI) and receiving parenteral sedation. Children were assigned to active music therapy, passive music therapy, distraction therapy, and no intervention; measures included doses and numbers of sedation medications, time of sedation, and salivary levels of the stress hormone cortisol and pro-inflammatory cytokines, before and immediately after the intervention was completed. The Time Frame for the outcome measures are at the start of the intervention and immediately following the procedure (generally about 150 minutes). No further follow up was conducted.
Status | Completed |
Enrollment | 471 |
Est. completion date | August 2012 |
Est. primary completion date | August 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 1 Year to 12 Years |
Eligibility |
Inclusion Criteria: - Children ages 1-12 years undergoing MRI studies Exclusion Criteria: - Patients with significant congenital anomalies, genetic syndromes and central nervous system malformations |
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Wayne State University and Children's Hospital of Michigan | Detroit | Michigan |
Lead Sponsor | Collaborator |
---|---|
Wayne State University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Need for sedation medications for MRI is reduced | Intervention is performed prior to sedation. Following sedation, the patient undergoes MRI. After the MRI is completed, the amount of sedation given to the patient is recorded. No other follow up is required. | The Time Frame for the outcome measures are at the start of the intervention and immediately following the procedure (average about 150 minutes). No further follow up was conducted. | No |
Secondary | To measure the effect of the interventions on salivary cortisol and inflammatory cytokines | The aim of this measure was to determine if the interventions changed the levels of salivary cortisol and inflammatory cytokines | Saliva samples were collected before the intervention and then after the MRI was performed (average about 150 minutes). | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01589289 -
Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases in Neurological Disorders in DRC
|
Phase 3 | |
Completed |
NCT00010881 -
Oregon Center for Complementary and Alternative Medicine in Neurological Disorders
|
N/A | |
Recruiting |
NCT04461821 -
Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and Adolescents
|
||
Completed |
NCT04094571 -
Muscle Delay Characterization
|
N/A | |
Completed |
NCT04072536 -
Evaluation on Standardized Circuits of the Interest of a Robotic Module of Assistance to the Driving
|
N/A | |
Recruiting |
NCT02795052 -
Neurologic Stem Cell Treatment Study
|
N/A | |
Completed |
NCT02219269 -
A Complex Contraception Registry
|
N/A | |
Completed |
NCT00122174 -
Stress-Busting Program for Caregivers of Patients With Neruological Diseases
|
N/A | |
Recruiting |
NCT01524276 -
Product Surveillance Registry
|
||
Completed |
NCT00532571 -
Effects of Coenzyme Q10 in PSP and CBD
|
Phase 2/Phase 3 | |
Completed |
NCT05830981 -
Valproic Acid Use in Patients With Neurological Disorders
|
||
Completed |
NCT01754168 -
Amyloid Beta and Cognition in Parkinson Disease
|
N/A | |
Completed |
NCT02780531 -
Genetic and Blood Biomarkers in Neurological and Neuromuscular Diseases
|
||
Suspended |
NCT05212727 -
Development and Validation of a Novel Functional Eye-Tracking Software Application for Neurological Disorders
|
||
Recruiting |
NCT01266382 -
The Effect of AposTherapy on the Level of Pain, Function and Quality of Life in Patients With Neuro-muscular and Neurological Disorders
|
N/A |